bibliographicCitation |
Hass HG, Bock T, Nehls O, Kaiser S. Rapid HBV DNA decrease (week 12) is an important prognostic factor for first-line treatment with adefovir dipivoxil for chronic hepatitis B. Journal of Gastroenterology. 2009 May 21;44(8):871–7. doi: 10.1007/s00535-009-0078-y. |